Putnam Investments’s Core Laboratories CLB Stock Holding History

Putnam Investments’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-18,205	Closed	-$2.26M	–	1271
2016 Q2	$2.26M	Hold	18,205	–	–	0.01%	890
2016 Q1	$2.05M	Sell	18,205 -15,500	-46%	-$1.61M	﹤0.01%	949
2015 Q4	$3.67M	Sell	33,705 -4,320	-11%	-$495K	0.01%	781
2015 Q3	$3.79M	Hold	38,025	–	–	0.01%	774
2015 Q2	$4.34M	Buy	+38,025	New	+$4.61M	0.01%	783

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Putnam Investments's CLB Position: Q3 2016 in Review

Putnam Investments sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 18,205 shares — an estimated $2.26M sold.

Putnam Investments first reported a position in CLB in Q2 2015 and held it in 5 quarters. The position peaked at $4.34M in Q2 2015. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Putnam Investments reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Putnam Investments sold 18,205 Core Laboratories shares in Q3 2016, an estimated $2.26M.
Putnam Investments first reported a position in Core Laboratories in Q2 2015 and held it in 5 quarters.
Putnam Investments's Core Laboratories position peaked at $4.34M in Q2 2015.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.